Prevention and Treatment of Diabetic Late ComplicationsCarl Erik Mogensen, Eberhard Standl Walter de Gruyter, 1989 - 226 páginas A fairly broad, but not comprehensive, review of the major complications in diabetes. The ten papers summarize the present knowledge on the important pathogenetic and classification systems with respect to the various entities of complication, and describe recent advances in treatment procedures. Topics include microalbuminuria, retinopathy, neuropathy, heart disease, cerebral and peripheral vascular disease, and the general monitoring of complications. Annotation copyrighted by Book News, Inc., Portland, OR |
Índice
History of diabetic complications | 1 |
NIDDM | 29 |
Diabetic retinopathy | 75 |
Neuropathy | 93 |
Diabetes and heart disease | 151 |
Cerebral and peripheral vascular disease | 169 |
General monitoring of risk factors and late complications | 199 |
| 223 | |
Otras ediciones - Ver todo
Prevention and Treatment of Diabetic Late Complications Carl E. Mogensen,Eberhard Standl Vista previa restringida - 2011 |
Prevention and Treatment of Diabetic Late Complications Carl Erik Mogensen,Eberhard Standl Vista de fragmentos - 1989 |
Prevention and Treatment of Diabetic Late Complications Carl Erik Mogensen,Eberhard Standl Vista de fragmentos - 1989 |
Términos y frases comunes
abnormalities albumin excretion rate aldose reductase inhibitor antihypertensive antihypertensive treatment associated atherosclerosis autonomic neuropathy axonal basement membrane blood glucose blood pressure capillary cardiac cardiovascular cholesterol Clin coronary artery coronary heart disease correlation CSII diabetes duration diabetes mellitus diabetic complications diabetic neuropathy diabetic patients diabetic retinopathy Diabetologia diagnosis disease in diabetes distal symmetric polyneuropathy duration of diabetes effect endothelial cells Engl follow-up function glomerular glycemic control glycosylation haemorrhages HbA1c hyperglycemia hypertension IDDM impaired incidence increased insulin insulin-dependent diabetes intervention kidney lesions levels lipid lipoprotein macrovascular disease microalbuminuria microaneurysms microangiopathy Mogensen mortality myelinated myo-inositol nerve conduction velocity NIDDM NIDDM patients normal onset pathogenesis peripheral nerve persistent proteinuria plasma platelet prevalence progression proliferative retinopathy protein proteinuria rats reduced renal disease retinal risk factors sensory sorbitol strict metabolic control suppl sural nerve symptoms therapy tissue triglycerides UalbV urinary albumin excretion urine vascular disease vessels µg/min